{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:09:32Z","timestamp":1789477772791,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NIH","award":["R01AI146917"],"award-info":[{"award-number":["R01AI146917"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bull Math Biol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11538-026-01717-0","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:51:23Z","timestamp":1786020683000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mathematical Modeling of HDV RNA, HBV DNA, and HBsAg Dynamics During Lonafarnib-Based Therapy: Insights from the LOWR HDV-1 Study"],"prefix":"10.1007","volume":"88","author":[{"given":"Adquate","family":"Mhlanga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Shekhtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Zakh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Duehren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Churkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Reinharz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Barash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Glenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ohad","family":"Etzion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott J.","family":"Cotler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cihan","family":"Yurdaydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harel","family":"Dahari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"1717_CR300","doi-asserted-by":"publisher","unstructured":"Battistella S, Pocurull A, Leonel T, Rodr\u00edguez-Tajes S, Fundora Y, Shekhtman L, Hershkovich L, Cotler SJ, Dahari H, Fortney T, Anderson M, Cloherty G, Hurtado JC, Saez-Palma M, Lens S, P\u00e9rez-Del-Pulgar S, Forns X (2026) Early hepatitis B and delta virus kinetics in patients undergoing liver transplantation. Sci Rep.  https:\/\/doi.org\/10.1038\/s41598-026-52234-y","DOI":"10.1038\/s41598-026-52234-y"},{"key":"1717_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-9485-1","volume-title":"Pharmacokinetic-pharmacodynamic modeling and simulation","author":"P Bonate","year":"2011","unstructured":"Bonate P (2011) Pharmacokinetic-pharmacodynamic modeling and simulation, 2nd Edition. Springer, New York, NY","edition":"2nd Edition"},{"key":"1717_CR2","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1002\/hep.22874","volume":"49","author":"H Dahari","year":"2009","unstructured":"Dahari H, Cotler SJ, Layden TJ, Perelson AS (2009a) Hepatitis B virus clearance rate estimates. Hepatology 49:1779\u20131780","journal-title":"Hepatology"},{"key":"1717_CR3","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.1128\/JVI.02612-08","volume":"83","author":"H Dahari","year":"2009","unstructured":"Dahari H, Sainz B Jr., Perelson AS, Uprichard SL (2009b) Modeling subgenomic hepatitis C virus RNA kinetics during treatment with alpha interferon. J Virol 83:6383\u20136390","journal-title":"J Virol"},{"key":"1717_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012512","author":"BC de Sousa","year":"2010","unstructured":"de Sousa BC, Cunha C (2010) Development of mathematical models for the analysis of hepatitis delta virus viral dynamics. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0012512","journal-title":"PLoS ONE"},{"key":"1717_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101070","volume":"6","author":"S El Messaoudi","year":"2024","unstructured":"El Messaoudi S, Brichler S, Fougerou-Leurent C, Gordien E, Gerber A, Kortebi A, Lagadic G, Subic-Levrero M, Metivier S, Pol S, Minello A, Ratziu V, Leroy V, Mathurin P, Alric L, Coulibaly F, Pawlotsky JM, Zoulim F, de L\u00e9dinghen V, Guedj J (2024) Effect of Peg-IFN on the viral kinetics of patients with HDV infection treated with bulevirtide. JHEP Rep 6:101070","journal-title":"JHEP Rep"},{"key":"1717_CR6","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jhep.2015.03.011","volume":"63","author":"K Giersch","year":"2015","unstructured":"Giersch K, Allweiss L, Volz T, Helbig M, Bierwolf J, Lohse AW, Pollok JM, Petersen J, Dandri M, L\u00fctgehetmann M (2015) Hepatitis delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection. J Hepatol 63:346\u2013353","journal-title":"J Hepatol"},{"key":"1717_CR7","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1126\/science.1598578","volume":"256","author":"JS Glenn","year":"1992","unstructured":"Glenn JS, Watson JA, Havel CM, White JM (1992) Identification of a prenylation site in delta virus large antigen. Science 256:1331\u20131333","journal-title":"Science"},{"key":"1717_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jtbi.2016.03.018","volume":"398","author":"A Goyal","year":"2016","unstructured":"Goyal A, Murray JM (2016) Dynamics of in vivo hepatitis D virus infection. J Theor Biol 398:9\u201319","journal-title":"J Theor Biol"},{"key":"1717_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.antiviral.2017.06.019","volume":"144","author":"A Goyal","year":"2017","unstructured":"Goyal A, Lurie Y, Meissner EG, Major M, Sansone N, Uprichard SL, Cotler SJ, Dahari H (2017) Modeling HCV cure after an ultra-short duration of therapy with direct acting agents. Antivir Res 144:281\u2013285","journal-title":"Antivir Res"},{"key":"1717_CR10","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1002\/hep.27357","volume":"60","author":"J Guedj","year":"2014","unstructured":"Guedj J, Rotman Y, Cotler SJ, Koh C, Schmid P, Albrecht J, Haynes-Williams V, Liang TJ, Hoofnagle JH, Heller T, Dahari H (2014) Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon-alpha therapy via mathematical modeling. Hepatology 60:1902\u20131910","journal-title":"Hepatology"},{"key":"1717_CR201","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1082069","volume":"10","author":"J Hercun","year":"2023","unstructured":"Hercun J, Heller T, Glenn JS, Kleiner DE, Koh C (2023) Distinct histological patterns in chronic hepatitis D with nucleos(t)ide analogue therapy. Front Med (Lausanne). 10:1082069. https:\/\/doi.org\/10.3389\/fmed.2023.1082069","journal-title":"Front Med (Lausanne)"},{"key":"1717_CR11","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41598-020-80594-6","volume":"11","author":"S Kadelka","year":"2021","unstructured":"Kadelka S, Dahari H, Ciupe SM (2021) Understanding the antiviral effects of RNAi-based therapy in HBeAg-positive chronic hepatitis B infection. Sci Rep 11:200","journal-title":"Sci Rep"},{"key":"1717_CR12","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S1473-3099(15)00074-2","volume":"15","author":"C Koh","year":"2015","unstructured":"Koh C, Canini L, Dahari H, Zhao X, Uprichard SL, Haynes-Williams V, Winters MA, Subramanya G, Cooper SL, Pinto P, Wolff EF, Bishop R, Han MAT, Cotler SJ, Kleiner DE, Keskin O, Idilman R, Yurdaydin C, Glenn JS, Heller T (2015) Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial. Lancet Infect Dis 15:1167\u20131174","journal-title":"Lancet Infect Dis"},{"key":"1717_CR13","doi-asserted-by":"publisher","DOI":"10.1201\/b17203","volume-title":"Mixed effects models for the population approach: models, tasks, methods and tools","author":"M Lavielle","year":"2014","unstructured":"Lavielle M (2014) Mixed effects models for the population approach: models, tasks, methods and tools, 1st ed. Chapman & Hall\/CRC, Boca Raton, FL","edition":"1st ed."},{"key":"1717_CR14","unstructured":"Lixoft. 2024. 'Monolix Suite 2024R1: Release Notes.', Lixoft. https:\/\/lixoft.com\/downloads\/release-notes-monolixsuite2024r1\/. Accessed 02 Sep 2024"},{"key":"1717_CR15","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.jhep.2023.01.005","volume":"78","author":"J Lucifora","year":"2023","unstructured":"Lucifora J, Alfaiate D, Pons C, Michelet M, Ramirez R, Fusil F, Amirache F, Rossi A, Legrand A-F, Charles E, Vegna S, Farhat R, Rivoire M, Passot G, Gadot N, Testoni B, Bach C, Baumert TF, Hyrina A, Beran RK, Zoulim F, Boonstra A, B\u00fcning H, Verrier ER, Cosset F-L, Fletcher SP, Salvetti A, Durantel D (2023) Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and -independent mechanisms. J Hepatol 78:958\u2013970","journal-title":"J Hepatol"},{"key":"1717_CR16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/hep.24758","volume":"55","author":"M L\u00fctgehetmann","year":"2012","unstructured":"L\u00fctgehetmann M, Mancke LV, Volz T, Helbig M, Allweiss L, Bornscheuer T, Pollok JM, Lohse AW, Petersen J, Urban S, Dandri M (2012) Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation. Hepatology 55:685\u2013694","journal-title":"Hepatology"},{"key":"1717_CR17","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1128\/JCM.00084-10","volume":"48","author":"I Mederacke","year":"2010","unstructured":"Mederacke I, Bremer B, Heidrich B, Kirschner J, Deterding K, Bock T, Wursthorn K, Manns MP, Wedemeyer H (2010) Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics. J Clin Microbiol 48:2022\u20132029","journal-title":"J Clin Microbiol"},{"key":"1717_CR18","volume":"10","author":"A Mhlanga","year":"2022","unstructured":"Mhlanga A, Zakh R, Churkin A, Reinharz V, Glenn JS, Etzion O, Cotler SJ, Yurdaydin C, Barash D, Dahari H (2022) Modeling the interplay between HDV and HBV in chronic HDV\/HBV patients. Mathematics (Basel) 10:3917","journal-title":"Mathematics (Basel)"},{"key":"1717_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.mbs.2013.10.004","volume":"247","author":"A Packer","year":"2014","unstructured":"Packer A, Forde J, Hews S, Kuang Y (2014) Mathematical models of the interrelated dynamics of hepatitis D and B. Math Biosci 247:38\u201346","journal-title":"Math Biosci"},{"key":"1717_CR20","first-page":"1807219","volume":"7","author":"T Plaire","year":"2018","unstructured":"Plaire T, Jules TJ, Bowong S (2018) Modelling and analysis of a within-host model of hepatitis B and D co-infections. BIOMATH 7:1807219","journal-title":"BIOMATH"},{"key":"1717_CR21","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00492-20","volume":"95","author":"V Reinharz","year":"2021","unstructured":"Reinharz V, Ishida Y, Tsuge M, Durso-Cain K, Chung TL, Tateno C, Perelson AS, Uprichard SL, Chayama K, Dahari H (2021) Understanding hepatitis B virus dynamics and the antiviral effect of interferon alpha treatment in humanized chimeric mice. J Virol 95:e0049220","journal-title":"J Virol"},{"key":"1717_CR22","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.cub.2018.01.077","volume":"28","author":"F Rieche","year":"2018","unstructured":"Rieche F, Carmine-Simmen K, Poeck B, Kretzschmar D, Strauss R (2018) Drosophila full-length amyloid precursor protein is required for visual working memory and prevents age-related memory impairment. Curr Biol 28:817\u201323.e3","journal-title":"Curr Biol"},{"key":"1717_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415973","author":"DG Sausen","year":"2022","unstructured":"Sausen DG, Shechter O, Bietsch W, Shi Z, Miller SM, Gallo ES, Dahari H, Borenstein R (2022) Hepatitis B and hepatitis D viruses: a comprehensive update with an immunological focus. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232415973","journal-title":"Int J Mol Sci"},{"key":"1717_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-64122-0","volume":"10","author":"L Shekhtman","year":"2020","unstructured":"Shekhtman L, Cotler SJ, Hershkovich L, Uprichard SL, Bazinet M, Pantea V, Cebotarescu V, Cojuhari L, Jimbei P, Krawczyk A, Dittmer U, Vaillant A, Dahari H (2020) Modelling hepatitis D virus RNA and HBsAg dynamics during nucleic acid polymer monotherapy suggest rapid turnover of HBsAg. Sci Rep 10:7837","journal-title":"Sci Rep"},{"key":"1717_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100966","volume":"6","author":"L Shekhtman","year":"2024","unstructured":"Shekhtman L, Cotler SJ, Degasperi E, Anolli MP, Uceda Renteria SC, Sambarino D, Borghi M, Perbellini R, Facchetti F, Ceriotti F, Lampertico P, Dahari H (2024) Modelling HDV kinetics under the entry inhibitor bulevirtide suggests the existence of two HDV-infected cell populations. JHEP Rep 6:100966","journal-title":"JHEP Rep"},{"key":"1717_CR26","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1016\/j.jhep.2016.02.013","volume":"64","author":"C Sureau","year":"2016","unstructured":"Sureau C, Negro F (2016) The hepatitis delta virus: replication and pathogenesis. J Hepatol 64:S102\u2013S116","journal-title":"J Hepatol"},{"key":"1717_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/v11030263","author":"M Tsuge","year":"2019","unstructured":"Tsuge M, Uchida T, Walsh K, Ishida Y, Tateno C, Kumar U, Glenn JS, Koh C, Heller T, Uprichard SL, Dahari H, Chayama K (2019) Early multiphasic HBV infection initiation kinetics is not clone-specific and is not affected by hepatitis D virus (HDV) infection. Viruses. https:\/\/doi.org\/10.3390\/v11030263","journal-title":"Viruses"},{"key":"1717_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105250","volume":"198","author":"ER Verrier","year":"2022","unstructured":"Verrier ER, Salvetti A, Pons C, Michelet M, Rivoire M, Baumert TF, Durantel D, Lucifora J (2022) Loss of hepatitis D virus infectivity upon farnesyl transferase inhibitor treatment associates with increasing RNA editing rates revealed by a new RT-ddPCR method. Antivir Res 198:105250","journal-title":"Antivir Res"},{"key":"1717_CR29","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/hep.29658","volume":"67","author":"C Yurdaydin","year":"2018","unstructured":"Yurdaydin C, Keskin O, Kalkan \u00c7, Karakaya F, \u00c7ali\u015fkan A, Karatayli E, Karatayli S, Bozdayi AM, Koh C, Heller T, Idilman R, Glenn JS (2018) Optimizing lonafarnib treatment for the management of chronic delta hepatitis: the LOWR HDV\u20101 study. Hepatology 67:1224\u20131236","journal-title":"Hepatology"},{"key":"1717_CR30","volume":"9","author":"R Zakh","year":"2021","unstructured":"Zakh R, Churkin A, Bietsch W, Lachiany M, Cotler SJ, Ploss A, Dahari H, Barash D (2021) A mathematical model for early HBV and -HDV kinetics during anti-HDV treatment. Mathematics (Basel) 9:3323","journal-title":"Mathematics (Basel)"}],"container-title":["Bulletin of Mathematical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11538-026-01717-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11538-026-01717-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11538-026-01717-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:55:23Z","timestamp":1789476923000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11538-026-01717-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1717"],"URL":"https:\/\/doi.org\/10.1007\/s11538-026-01717-0","relation":{},"ISSN":["0092-8240","1522-9602"],"issn-type":[{"value":"0092-8240","type":"print"},{"value":"1522-9602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"150"}}